These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 9269706

  • 1. The long-term tolerability of enalapril in hypertensive patients with renal impairment.
    Keane WF, Polis A, Wolf D, Faison E, Shahinfar S.
    Nephrol Dial Transplant; 1997; 12 Suppl 2():75-81. PubMed ID: 9269706
    [Abstract] [Full Text] [Related]

  • 2. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S, Mahajan SK, Sen R, Sharma A.
    J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
    [Abstract] [Full Text] [Related]

  • 3. Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.
    Applegate W, Cohen JD, Wolfson P, Davis A, Green S.
    Pharmacotherapy; 1997 Oct; 17(1):107-12. PubMed ID: 9017770
    [Abstract] [Full Text] [Related]

  • 4. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [Abstract] [Full Text] [Related]

  • 6. Clinical experience with lisinopril. Observations on safety and tolerability.
    Cameron HA, Higgins TJ.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():177-86. PubMed ID: 2550641
    [Abstract] [Full Text] [Related]

  • 7. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 8. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM, Aldigier JC, Ponticelli C, Oddou-Stock P, Botteri F, Mann JF.
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [Abstract] [Full Text] [Related]

  • 9. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ, Nanivadekar AS.
    J Assoc Physicians India; 1998 Jan; Suppl 1():52-62. PubMed ID: 11233387
    [Abstract] [Full Text] [Related]

  • 10. Treatment of hypertension in the very old.
    Otterstad JE, Ruilope LM.
    Int J Clin Pract Suppl; 2000 Nov; (114):10-9. PubMed ID: 11221289
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of enalapril/diltiazem ER in hypertensive patients with coexisting renal dysfunction. Enalapril/Diltiazem ER in Hypertensive Renal Disease Group.
    Hricik DE, Levine BS, Adrogue HJ, Weinberg MS, Goldstein R.
    J Hum Hypertens; 1996 Nov; 10(11):769-74. PubMed ID: 9004108
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B.
    Curr Med Res Opin; 2001 Nov; 17(1):8-17. PubMed ID: 11464450
    [Abstract] [Full Text] [Related]

  • 15. [The antagonistic effect of aspirin on the expression of prostaglandin participation in the antihypertensive activity of ACE inhibitors].
    Alimento M, Campodonico J, Santambrogio G, Rossi M, Trabattoni D, Celeste F, Guazzi M.
    Cardiologia; 1997 Jun; 42(6):605-10. PubMed ID: 9289376
    [Abstract] [Full Text] [Related]

  • 16. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies.
    Naidoo DP, Sareli P, Marin F, Aroca-Martinez G, Maritz FJ, Jardim PC, Guerrero AA, Thompson CA, Bero T, Drazka J, Kosmalova V, Dumortier T, Smith RD.
    Adv Ther; 1999 Jun; 16(5):187-99. PubMed ID: 10915394
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A, Gil-Extremera B, Calvo C, Campo C, García-Puig J, Márquez E, Oliván J, Roca Cusachs A, Sanz de Castro S, Pontes C, Delgadillo J.
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [Abstract] [Full Text] [Related]

  • 18. Enalapril: benefit-to-risk ratio in hypertensive patients.
    Gomez HJ, Cirillo VJ, Smith SG.
    J Cardiovasc Pharmacol; 1990 Mar; 15 Suppl 3():S26-9. PubMed ID: 1691415
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.